Talzenna 0.75 MG Oral Capsule

RxCUI: 2591521
RxNorm name: Talzenna 0.75 MG Oral Capsule
Display name: Talzenna 0.75 MG Oral Capsule
Full name: Talzenna 0.75 MG Oral Capsule
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Talzenna	TALAZOPARIB	Pfizer Laboratories Div Pfizer Inc	c6fd147f-a77e-4a0b-9280-e82ecc41b4be	2026-04-10	Warnings, Adverse reactions	Exact identifier rxcui: 2591521
Talzenna	TALAZOPARIB	Pfizer Laboratories Div Pfizer Inc	f2423edd-6d24-495c-aec1-c2f457f08d9a	2025-12-18	Warnings, Adverse reactions	Exact identifier rxcui: 2591521

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
f2423edd-6d24-495c-aec1-c2f457f08d9a	Talzenna 0.75 MG Oral Capsule [PSN] · talazoparib 0.75 MG Oral Capsule [Talzenna] [SBD] · Talzenna 0.75 MG Oral Capsule [SY]	3	19	These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 2018	20251218
c6fd147f-a77e-4a0b-9280-e82ecc41b4be	Talzenna 0.75 MG Oral Capsule [PSN] · talazoparib 0.75 MG Oral Capsule [Talzenna] [SBD] · Talzenna 0.75 MG Oral Capsule [SY]	3	4	These highlights do not include all the information needed to use TALZENNA safely and effectively. See full prescribing information for TALZENNA. TALZENNA ® (talazoparib) capsules, for oral use Initial U.S. Approval: 2018	20260410